Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

What Side Effects? Drug Ads With Warnings May Spur More Sales
Pharmalot
Thursday, September 26, 2013 - 8:17am
tags:
drug ads, side effects, warnings
Lilly drug fails in breast cancer, succeeds in gastric cancer
Reuters
Thursday, September 26, 2013 - 8:14am
tags:
Eli Lilly, gastric cancer, breast cancer, ramucirumab
Novartis says "deep regret" over Japan drug trials scandal
Reuters
Thursday, September 26, 2013 - 8:13am
tags:
Novartis, Japan, clinical trials
Does Conatus Pharmaceuticals Have A Winner With Emricasan?
Seeking Alpha
Thursday, September 26, 2013 - 8:12am
tags:
Conatus Pharmaceuticals, emricasan, Gilead, Merck, Pfizer, liver disease, Sunesis, apoptosis
Does Merck's R&D Program Need a Wake-Up Call?
Motley Fool
Thursday, September 26, 2013 - 8:09am
tags:
R&D, Merck, drug approvals, sugammadex, Pfizer, Eli Lilly, Sanofi, AstraZeneca
Will 3 Versions of Pfizer Be More Valuable Than 1?
Motley Fool
Wednesday, September 25, 2013 - 3:16pm
tags:
Pfizer, spinoffs, Zoetis
Pacific Biosciences Rockets on Roche Diagnostics Deal
Motley Fool
Wednesday, September 25, 2013 - 1:11pm
tags:
Roche, diagnostics, Pacific Biosciences
FierceBiotech's 2013 Fierce 15
Fierce Biotech
Wednesday, September 25, 2013 - 1:04pm
tags:
biotech, AnaptysBio, Acetylon Pharmaceuticals, CytomX, Immunocore, FibroGen, Jounce Therapeutics, Kala Pharmaceuticals, Macrogenics, Moderna Therapeutics, Presage Biosciences, Nimbus Discovery, Scioderm, Ultragenyx, uniQure, Visterra
A Closer Look at 4 Pharmaceutical Giants
Motley Fool
Wednesday, September 25, 2013 - 11:02am
tags:
Merck, Pfizer, JNJ, GSK
Infinity Pharma's cancer drug fails mid-stage trial goals
Reuters
Wednesday, September 25, 2013 - 10:41am
tags:
Infinity Pharma, non-small cell lung cancer, retaspimycin
Novo Nordisk And A Questionable Form Of Victoza Promotion?
Pharmalot
Wednesday, September 25, 2013 - 10:35am
tags:
Novo Nordisk, Victoza, diabetes
Mylan being sued by Forest Labs over generic version of Savella
The Fly on the Wall
Wednesday, September 25, 2013 - 10:34am
tags:
Mylan, Forest Labs, generics, Savella
Oncothyreon is a potential target of Merck KGaA, says Cowen
Yahoo/Fly on the Wall
Wednesday, September 25, 2013 - 10:33am
tags:
M&A, Oncothyreon, Merck KGaA
Government shutdown would likely roil FDA's drug-approval process
Fierce Biotech
Wednesday, September 25, 2013 - 9:34am
tags:
drug approvals, FDA
Ophthotech, Foundation Medicine loot booming biotech IPO market for $273M
Fierce Biotech
Wednesday, September 25, 2013 - 9:29am
tags:
Ophthotech, IPOs, Foundation Medicine
Amarin says Vascepa study surpassed 6,000 patients
Yahoo/Fly on the Wall
Wednesday, September 25, 2013 - 9:25am
tags:
Amarin, Vascepa, clinical trials
Making The Call: Onconova MDS Drug Study Will Succeed
TheStreet.com
Wednesday, September 25, 2013 - 9:21am
tags:
Onconova, MDS, Rigosertib, Celgene
Johnson & Johnson, Cardinal Health Win Pentagon Contracts
Motley Fool
Wednesday, September 25, 2013 - 9:14am
tags:
Cardinal Health, JNJ, government contracts
Stryker to buy Mako Surgical for $1.65 billion
Reuters
Wednesday, September 25, 2013 - 9:06am
tags:
devices, M&A, Mako Surgical, Stryker
OncoMed granted additional broad anti-RSPO antibody patent in U.S.
Yahoo/Fly on the Wall
Wednesday, September 25, 2013 - 9:03am
tags:
OncoMed, anti-RSPO, patents, antibodies

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.